MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.fertnstert.2025.09.013

Медицинская библиотека · Fertility and sterility · 2025

Polycystic ovary syndrome and elevated body mass index independently increase type 2 diabetes risk with obesity-mediated risk dominating: a real-world data analysis of US patients.

Sharafutdinov Konstantin, Hilpert Jan, Burghaus Rolf, Diedrich Christian, Lippert Jörg, Scheerans Christian, Schaper Steffen

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To study the relationship between polycystic ovary syndrome (PCOS) and type 2 diabetes mellitus (T2DM) in a retrospective US cohort.

DESIGN

Longitudinal case-control study.

SUBJECTS: The study utilized data from the IBM Explorys database, a comprehensive real-world dataset containing deidentified, longitudinal patient-level electronic health records from approximately 400 hospitals across the United States. The study population consisted of women diagnosed with PCOS between 2000 and 2020, aged 25 to 55 years (n = 42,030) and control women without PCOS (n = 84,060), matched 1:2 by ethnicity, geographic region, age, and body mass index (BMI). Additionally, a secondary control group (n = 42,030) was employed, matched on all covariates except BMI.

EXPOSURE: The PCOS status was identified using International Classification of Disease -coded diagnoses, whereas T2DM diagnosis was determined using International Classification of Disease-coded diagnoses as well as hemoglobin A1c levels.

MAIN OUTCOME MEASURES: The incidence of T2DM.

RESULTS

The 3-year cumulative incidence rates of T2DM in the PCOS and non-PCOS cohorts were 9.2% (95% Confidence Interval: 8.9%-9.5%) and 6.0% (5.8%-6.2%), respectively. The 15-year cumulative incidence rates were 34.3% (31.4%-37.4%) and 22.6% (21.2%-24.1%), respectively. The adjusted hazard ratio (HR) of T2DM in women with PCOS was 1.47 (1.41-1.53) compared with control individuals. The HRs for PCOS were found to be consistent in different BMI strata ranging from 1.37 in the obese class III subgroup to 1.78 in the subgroup with normal weight. The median BMI in the PCOS cohort was 34.86 kg/m2, in contrast to 27.26 kg/m2 in non-PCOS controls not matched for BMI. The additional HR for T2DM associated with this BMI difference of 7.6 kg/m2 is estimated to be 1.87 (1.82-1.92).

CONCLUSION

In the current analysis, PCOS was independently associated with increased T2DM incidence across all BMI categories. Moreover, the elevated BMI in patients with PCOS confers additional T2DM risk mediated by excess adiposity. This BMI-mediated risk exceeds the risk associated with PCOS through other mechanisms, such as hyperandrogenism.

Для цитирования: Sharafutdinov Konstantin, Hilpert Jan, Burghaus Rolf, Diedrich Christian, Lippert Jörg, Scheerans Christian, Schaper Steffen. Polycystic ovary syndrome and elevated body mass index independently increase type 2 diabetes risk with obesity-mediated risk dominating: a real-world data analysis of US patients.. Fertility and sterility. 2025. DOI: 10.1016/j.fertnstert.2025.09.013.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.